S 05985 combination versus angiotensin II receptor blocker/calcium channel blocker: a comparison of blood pressure lowering - efficacy and safety
Phase 3
Completed
- Conditions
- Essential arterial hypertensionCirculatory SystemArterial hypertension
- Registration Number
- ISRCTN59214686
- Lead Sponsor
- Institut de Recherches Internationales Servier (France)
- Brief Summary
2015 results in https://www.ncbi.nlm.nih.gov/pubmed/25380149
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1600
Inclusion Criteria
1. Outpatients
2. Men or women
3. Aged 18 years old at least
4. Mild to moderate hypertensive patient
Exclusion Criteria
1. Pregnancy or breastfeeding women
2. Secondary hypertension
3. Any patient suffering from an acute or chronic illness
4. Contraindication to any study treatments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Efficacy of S 05985 combination versus comparator in blood pressure lowering <br>2. Safety assessment of treatments
- Secondary Outcome Measures
Name Time Method 1. Efficacy of both combination strategies on ABPM parameters<br>2. Long-term safety assessment of S 05985 combination (14 months)